Market cap
$710m
Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.
Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.
For the six months ended June 30, 2025, we had net income of $2.7 million and net income attributable to common stockholders of $0.1 million. Components of Results of Operations Revenues Sales of Pharmaceutical Products We generate revenue primarily through sales of ETUARY TM , Contiva TM , Etorel TM and certain generic drugs in the PRC. Distributors are our direct customers, and sales to distributors accounted for 100% of the revenue. …GYRE THERAPEUTICS, INC., 10-Q, period ended 2026-06-30, filed 2026-08-07